These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2243671)

  • 1. Efficacy of adding dipivefrin to a beta-blocker.
    Geyer O; Rothkoff L; Lazar M
    Ophthalmology; 1990 Oct; 97(10):1245-6. PubMed ID: 2243671
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of levobunolol and dipivefrin for the treatment of glaucoma.
    Allen RC; Robin AL; Long D; Novack GD; Lue JC; Kaplan G
    Arch Ophthalmol; 1988 Jul; 106(7):904-7. PubMed ID: 3291837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant glaucoma therapy with dipivefrin and timolol maleate.
    Thorson JC
    Trans Ophthalmol Soc N Z; 1981; 33():24-6. PubMed ID: 7020220
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic response interactions between timolol maleate and dipivefrin hydrochloride.
    West RH; Gillies WE; Brooks AM
    Aust N Z J Ophthalmol; 1987 May; 15(2):131-4. PubMed ID: 3620185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.
    Boozman FW; Carriker R; Foerster R; Allen RC; Novack GD; Batoosingh AL
    Arch Ophthalmol; 1988 May; 106(5):614-8. PubMed ID: 3282501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changing medication regimens in glaucoma patients.
    Novack GD; David R; Lee PF; Freeman MI; Duzman E; Batoosingh AL
    Ophthalmologica; 1988; 196(1):23-8. PubMed ID: 3279366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.
    Keates EU; Stone RA
    Am J Ophthalmol; 1981 Feb; 91(2):243-8. PubMed ID: 7468740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
    Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].
    Ober M; Scharrer A
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1980; 213(4):273-81. PubMed ID: 6906160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R; Ober M; Masi R; Elman J; Novack GD; Sears ML; Batoosingh AL
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs and glaucoma.
    Soll DB; Saxon AM
    Am Fam Physician; 1986 Jul; 34(1):181-5. PubMed ID: 2873739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
    Frishman WH; Fuksbrumer MS; Tannenbaum M
    J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levobunolol vs timolol for open-angle glaucoma and ocular hypertension.
    Cinotti A; Cinotti D; Grant W; Jacobs I; Galin M; Silverstone D; Shin D; Esters J; Lee J; Bouchey R
    Am J Ophthalmol; 1985 Jan; 99(1):11-7. PubMed ID: 3881032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
    Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
    Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.